Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
2003 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Decrease in serum C-reactive protein levels by troglitazone is associated with pretreatment insulin resistance, but independent of its effect on glycemia, in type 2 diabetic subjects
2003
Glitazones and the management of insulin resistance: what they do and how might they be used
2004
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency
2009
Thiazolidinediones
2004 Standout
Acromegaly
2006 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Quantitative Measurement of IGF-I and Its Use in Diagnosing and Monitoring Treatment of Disorders of Growth Hormone Secretion
2005
Psoriasis
2009 Standout
Thyroid cancer
2016 Standout
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
2010
Pathogenesis and clinical features of psoriasis
2007 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Vitamin D deficiency in children and adolescents: Epidemiology, impact and treatment
2008
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
2008 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Laboratory challenges in primary aldosteronism screening and diagnosis
2015
The metabolic syndrome
2010 Standout
The GPR54 Gene as a Regulator of Puberty
2003 Standout
C-reactive protein: a critical update
2003 Standout
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
2010 Standout
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Psoriasis
2021 Standout
Inflammatory Bowel Disease
2009 Standout
Inflammation, stress, and diabetes
2005 Standout
Inflammation and insulin resistance
2006 Standout
Psoriasis
2015 Standout
The metabolic syndrome
2005 Standout
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Type 2 diabetes
2017 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Effect of plasminogen activator inhibitor–1 in diabetes mellitus and cardiovascular disease
2003
A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes
2007
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
An immune origin of type 2 diabetes?
2005
Obesity, Inflammation, and Insulin Resistance
2007
Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B–containing lipoproteins
2008 StandoutNobel
Metformin—mode of action and clinical implications for diabetes and cancer
2014
C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones
2004
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Chronic Kidney Disease
2016 Standout
Vitamin D deficiency: a worldwide problem with health consequences
2008 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Secretion of Unconjugated Androgens and Estrogens by the Normal and Abnormal Human Testis before and after Human Chorionic Gonadotropin
1974
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
Familial Incomplete Male Pseudohermaphroditism, Type 2
1974 StandoutNobel
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Familial Incomplete Male Pseudohermaphroditism, Type 1
1974 StandoutNobel
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Gonadotropin-Releasing Hormone Deficiency in the Human (Idiopathic Hypogonadotropic Hypogonadism and Kallmann’s Syndrome): Pathophysiological and Genetic Considerations
1998
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
2003 Standout
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention
2003 Standout
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus
2002
Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
2003
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Vitamin D3 Is More Potent Than Vitamin D2 in Humans
2010
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
2004
Vitamin D and Skin Physiology: A D-Lightful Story
2007
Update in Vitamin D
2010
Lipids and Lipoproteins in Patients With Type 2 Diabetes
2004
C-reactive protein: a critical update
2003 Standout
Differentiation Between Obesity and Insulin Resistance in the Association With C-Reactive Protein
2002
Bacterial intracranial aneurysm
1978
Works of Richard E. Reitz being referenced
Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism.
1974
Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria
2014
Identification of Four Gene Variants Associated with Myocardial Infarction
2005
Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults
2010
Variability and Reliability of single Serum IGF-I Measurements: Impact on Determining Predictability of Risk Ratios in Disease Development
2004
Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
2002
Regulation of Glucose Transport and Insulin Signaling by Troglitazone or Metformin in Adipose Tissue of Type 2 Diabetic Subjects
2002
Angiography for Mycotic Aneurysm
1969
Vitamin D2 Is as Effective as Vitamin D3 in Maintaining Circulating Concentrations of 25-Hydroxyvitamin D
2007
The Diagnosis of Congenital Adrenal Hyperplasia in the Newborn by Gas Chromatography/Mass Spectrometry Analysis of Random Urine Specimens
2002
Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk
2009
Plasma Renin Activity by LC-MS/MS: Development of a Prototypical Clinical Assay Reveals a Subpopulation of Human Plasma Samples with Substantial Peptidase Activity
2010
A Novel Mass Spectrometry–Based Assay for the Accurate Measurement of Thyroglobulin from Patient Samples Containing Antithyroglobulin Autoantibodies
2012